Berlin: German pharma companies BioNTech and its partner American pharmaceutical company Pfizer have stated that they have reported coronavirus to the European Medicines Agency. Has handed over an application for approval of their vaccine.
Both the companies said on Tuesday that the review process of the application submitted on Monday has been completed. He had started it before the agency on October six. The US drug company Moderna has requested US and European regulators to allow emergency use of its Covid-19 vaccine.
One day at the request of rival company Moderna, these companies have taken this step. Bioentech has stated that the vaccine is currently renamed BNT162B2 and if approved, its use in Europe could begin before the end of 2020.
